Rob is Policy Director within GSK’s Office for the Chief Medical Officer (CMO).
The CMO is the ‘voice of the patient’ within GSK, leading the culture and governance framework to place the interests of the patient at the centre of research, development and commercialisation of medicines. The CMO has primary responsibility for matters of patient safety, general medical governance, medical ethics and integrity, medical information and investigations involving human subjects relating to any GSK product in development and on the market. As part of the Medical Policy group, Rob develops internal policies and GSK external positions and engagement plans in these areas.
Since joining GSK in 2011, Rob has supported the development of new transparency commitments around disclosure of clinical trial information, including the clinicalstudydatarequest.com initiative to provide external researchers with access to anonymised patient level trial data. He has also worked closely on topics relating to data privacy and ethics, including ongoing revisions to European data protection legislation.
Prior to joining GSK, Rob worked at the UK Academy of Medical Sciences on a series of policy projects addressing issues of medical science and healthcare in their wide scientific and societal context. This included leading the secretariat for the Academy’s review of the regulation and governance of health research, which informed the creation in 2011 of the Health Research Authority.